SHIELD Joint Action project launched – official announcement
Every year, more than two million people in Europe develop cancer, and one in eight of these cancer cases are caused by an infection that could have been prevented (HPV, hepatitis B…

Every year, more than two million people in Europe develop cancer, and one in eight of these cancer cases are caused by an infection that could have been prevented (HPV, hepatitis B…

There are few things I look forward to more each year than an excellent Christmas lunch. In fact, I deliberately avoid roast dinners in the run-up to the big day. Especially obligatory work parties, where the turkey inevitably resembles…

Viruses, as we all know, are invisibly small things that make us sick. But is that the whole story?
Zoom in close enough and you’ll discover the complex, unseen world of viruses. Some do make us sick, but many others simply exist…

As 2025 comes to a close, I’m proud to reflect on the incredible progress on typhoid control accomplished this year. During the last 12 months, more than 80 million children received typhoid conjugate vaccines (TCV) in introduction…

Washington, D.C., 16 December 2025 (PAHO/WHO) — In recent months, national immunization programs in 18 countries and territories across the Americas have strengthened their vaccine cold chain systems, ensuring vaccine potency and reinforcing…

Breast-conserving surgery (BCS) followed by adjuvant radiotherapy has largely replaced mastectomy as the standard treatment for early breast cancers due to its ability to preserve the breast while maintaining comparable oncological…

Combining neoadjuvant therapy with immunotherapy in patients with mismatched repair-proficient/microsatellite stable (pMMR/MSS) rectal cancer yielded high pathological and clinical response rates, excellent surgical outcomes, and a manageable…

Pharmacy Times: What do these real-world radiation patterns from S1007 tell us about how clinicians currently view the risk of pN1mi disease, particularly compared with macro metastatic nodal involvement?
Jose Bazan, MD: That’s a great…